查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1832092

2025 年至 2033 年医用迴旋加速器市场规模、份额、趋势和预测（按类型、产品类型、最终用户和地区）

Medical Cyclotron Market Size, Share, Trends and Forecast by Type, Product Type, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球医用迴旋加速器市场规模为2.475亿美元。展望未来， IMARC Group估计，到2033年，市场规模将达到4.783亿美元，2025-2033年期间的复合年增长率为7.22%。 2024年，亚太地区占据了市场主导地位。癌症盛行率的上升、放射性药物的进步、对正子断层扫描 (PET) 扫描的需求不断增长、技术创新、医疗保健基础设施的扩大、研究活动的增加以及政府推动核医学和诊断成像的支持性倡议，是影响医用迴旋加速器市场份额的一些关键因素。

由于多种关键因素，医疗迴旋加速器市场正稳步成长。其中一个主要驱动因素是对诊断影像程序的需求不断增长，尤其是正子断层扫描 (PET) 扫描，该扫描需要迴旋加速器产生的放射性同位素。全球癌症和心血管疾病发生率的上升进一步扩大了对早期准确诊断工具的需求。放射性药物和成像技术的进步提高了诊断的效率和准确性，鼓励更广泛地采用迴旋加速器系统。此外，新兴经济体医疗基础设施的不断扩大以及对核子医学投资的增加也支持了医疗迴旋加速器市场的成长。政府的支持性政策，包括对癌症诊断的资助以及医疗创新的公私合作，也正在发挥作用。此外，分散式同位素生产的转变以及诊断中心数量的增加，也增强了对紧凑型、医院用迴旋加速器的需求。

美国食品药物管理局 (FDA) 认证使用紧凑型迴旋加速器系统在内部生产镓-68，使医院和放射性药房能够在本地生产高活度诊断同位素。这项进展有助于更广泛地获取 PET 显影剂，减少对集中供应的依赖，并凸显了美国市场日益朝向分散式放射性药物生产的趋势。例如，2025 年 4 月，Telix ARTMS, Inc. 宣布，Gozellix 成为首个获得美国食品药品监督管理局 (FDA) 认证的产品，可参考药品主文件 (DMF)，使用 Telix ARTMS, Inc. 的 QUANTM 辐照系统迴旋加速器技术生产镓-68。获得此项批准后，放射性药局和医院将能够利用 ARTMS 的 QIS 迴旋加速器技术和相关靶材，产生 Gozellix 的多居里 68Ga。

医用迴旋加速器市场趋势：

癌症和慢性病发生率上升

推动市场发展的主要趋势之一是全球癌症和其他慢性疾病发生率的上升。癌症仍然是全球主要死因之一，因此需要先进的诊断工具进行早期发现和治疗。 2022年，全球癌症死亡人数达970万，癌症确诊人数达5350万。医用迴旋加速器在生产用于正子断层扫描（PET）的放射性同位素方面发挥着至关重要的作用，而PET扫描在早期检测各种癌症方面非常有效。此外，心血管疾病（CVD）和神经系统疾病等慢性疾病的盛行率不断上升，也增加了对精准诊断影像技术的需求。随着医疗保健系统强调早期诊断和有效的治疗方案，对可靠、高品质放射性同位素的需求正在推动医用迴旋加速器市场的成长。

放射性药物的进展

根据医用迴旋加速器市场前景，放射性药物在核医的诊断和治疗中发挥着至关重要的作用。最近的进展导致了更精确和更有针对性的放射性药物的开发，提高了诊断成像和治疗的准确性和有效性。放射性药物的这项创新扩大了其应用范围，使得诊断和治疗肿瘤学以外的更广泛疾病成为可能，包括心臟病学和神经病学。因此，根据IMARC Group的报告，2024 年全球放射性药物市场规模达到 58 亿美元。预计到 2033 年，该市场将达到 89 亿美元，在 2025-2033 年期间的复合年增长率为 4.9%。此外，人工智慧和机器学习 (ML) 在放射性药物研究中的结合刺激了新化合物的开发，改善了患者的治疗效果。这些进步使得生产新型放射性同位素成为必要，从而推动了医用迴旋加速器市场规模的成长。

扩大医疗保健基础设施和诊断影像投资

医疗迴旋加速器市场预测表明，医疗保健基础设施的扩张对市场成长做出了巨大贡献。例如，根据印度卫生和家庭福利部的数据，截至 2023 年 3 月，印度共有 1,69,615 个分中心 (SC)、31,882 个初级卫生中心 (PHC)、6,359 个社区卫生中心 (CHC)、1,340 个分区/地区医院 (SDH)、714 家农村地区医学院 (362) 家地区服务所 (362) 和农村地区医学院服务。公营和私营部门组织都在大力投资开发配备创新诊断影像技术的尖端医疗设施。医院和诊断诊所中 PET 和 PET-CT 中心的不断发展有助于市场成长。此外，政府积极的倡议和对核医学和诊断成像的支持也进一步促进了市场成长。例如，许多国家正在製定政策，以增强先进诊断设备和关键放射性药物的可及性。这对医用迴旋加速器市场的前景产生了有利影响，因为它们对于生产此类先进成像程序所需的放射性同位素至关重要。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球医用迴旋加速器市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 环形迴旋加速器
  • 方位变场（AVF）迴旋加速器

第七章：市场区隔：依产品类型

  • 迴旋加速器 10-12 MeV
  • 迴旋加速器 16-18 MeV
  • 迴旋加速器 19-24 MeV
  • 迴旋加速器 24 MeV 以上

第 8 章：市场区隔：依最终用户

  • 医院
  • 诊断中心
  • 研究与学术机构
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Advanced Cyclotron Systems Inc.
    • Alcen
    • Best Medical International Inc.
    • General Electric Company
    • IBA RadioPharma Solutions
    • Ionetix Corporation
    • Isosolution Inc.
    • Siemens AG
    • Sumitomo Heavy Industries Ltd.
    • Varian Medical Systems Inc.
Product Code: SR112025A4573

The global medical cyclotron market size was valued at USD 247.5 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 478.3 Million by 2033, exhibiting a CAGR of 7.22% during 2025-2033. Asia Pacific dominated the market in 2024. The increasing cancer prevalence, advancements in radiopharmaceuticals, rising demand for positron emission tomography (PET) scans, technological innovations, expanding healthcare infrastructure, growing research activities, and supportive government initiatives promoting nuclear medicine and diagnostic imaging are some of the key factors contributing to the medical cyclotron market share.

The market is growing steadily due to several key factors. One major driver is the increasing demand for diagnostic imaging procedures, particularly Positron Emission Tomography (PET) scans, which require radioisotopes produced by cyclotrons. The rising global incidence of cancer and cardiovascular diseases has further amplified the need for early and accurate diagnostic tools. Technological advancements in radiopharmaceuticals and imaging techniques have improved the efficiency and precision of diagnosis, encouraging greater adoption of cyclotron systems. Additionally, expanding healthcare infrastructure in emerging economies and rising investments in nuclear medicine support medical cyclotron market growth. Supportive government policies, including funding for cancer diagnostics and public-private partnerships in healthcare innovation, are also playing a role. Moreover, the shift toward decentralized isotope production and the increasing number of diagnostic centers have strengthened the demand for compact, hospital-based cyclotrons.

FDA certification for in-house gallium-68 production using compact cyclotron systems is enabling hospitals and radiopharmacies to locally manufacture diagnostic isotopes in high activity. This development supports wider access to PET imaging agents, reduces dependence on centralized supply, and underscores a growing move toward decentralized radiopharmaceutical manufacturing in the US market. For instance, in April 2025, Telix ARTMS, Inc. announced that Gozellix became the first product certified by the US Food and Drug Administration (FDA) to reference the drug master file (DMF) for gallium-68 production using Telix ARTMS, Inc.'s QUANTM Irradiation System cyclotron technology. With this approval, radiopharmacies and hospitals would be able to generate multi-Curies of 68Ga for use with Gozellix by utilizing ARTMS' QIS cyclotron technology and related targets.

Medical Cyclotron Market Trends:

Rising Prevalence of Cancer and Chronic Diseases

One of the primary trends driving the market is the increasing incidence of cancer and other chronic diseases worldwide. Cancer remains one of the leading causes of death globally, necessitating advanced diagnostic tools for early detection and treatment. In 2022, there were 9.7 million deaths due to cancer, and 53.5 million people living with a cancer diagnosis. Medical cyclotrons play a crucial role in producing radioisotopes used in PET scans, which are highly effective in detecting various types of cancers at an early stage. Additionally, the escalating prevalence of chronic diseases such as cardiovascular disorders (CVD) and neurological conditions has increased the demand for precise diagnostic imaging techniques. As healthcare systems emphasize early diagnosis and effective treatment plans, the need for reliable and high-quality radioisotopes is bolstering the medical cyclotron market growth.

Advancements in Radiopharmaceuticals

Based on the medical cyclotron market outlook, Radiopharmaceuticals play a crucial role in nuclear medicine for both diagnostic and therapeutic purposes. Recent advancements have led to the development of more precise and targeted radiopharmaceuticals, enhancing the accuracy and effectiveness of diagnostic imaging and treatments. This innovation in radiopharmaceuticals has expanded their application scope, enabling the diagnosis and treatment of a broader range of diseases beyond oncology, including cardiology and neurology. As a result, in 2024, the global radiopharmaceuticals market reached USD 5.8 Billion, as per a report by the IMARC Group. The market is further projected to reach USD 8.9 Billion by 2033, growing at a CAGR of 4.9% during 2025-2033. Moreover, the integration of AI and machine learning (ML) in radiopharmaceutical research has spurred the development of new compounds, improving patient outcomes. These advancements necessitate the production of novel radioisotopes, thereby providing an impetus to the medical cyclotron market size.

Expanding Healthcare Infrastructure and Investments in Diagnostic Imaging

The medical cyclotron market forecast indicates that the expansion of healthcare infrastructure significantly contributes to the market growth. For instance, in India, there are a total of 1,69,615 Sub-Centres (SCs), 31,882 Primary Health Centres (PHCs), 6,359 Community Health Centres (CHCs), 1,340 Sub-Divisional/District Hospitals (SDHs), 714 District Hospitals (DHs), and 362 Medical Colleges (MCs) serving both rural and urban areas as of March 2023, according to the Ministry of Health and Family Welfare. Both public and private sector organizations are making huge investments in the development of cutting-edge medical facilities equipped with innovative diagnostic imaging technologies. The rising development of PET and PET-CT centers in hospitals and diagnostic clinics is helping in market growth. Additionally, positive government initiatives and funding to support nuclear medicine and diagnostic imaging are further enhancing the market growth. For example, many nations are putting in place policies that enhance access to advanced diagnostic equipment and the availability of critical radiopharmaceuticals. This is having a favorable influence on the outlook of the medical cyclotron market since they are critical in the production of radioisotopes necessary for use in such advanced imaging procedures.

Medical Cyclotron Industry Segmentation:

Analysis by Type:

  • Ring Cyclotron
  • Azimuthally Varying Field (AVF) Cyclotron

As per the medical cyclotron market research report, the ring cyclotron stood as the largest component in 2024. As per the medical cyclotron industry statistics, ring cyclotrons dominate the market due to their superior capabilities in producing high-energy radioisotopes essential for advanced diagnostic imaging techniques like PET. Their design allows for continuous and efficient acceleration of particles, resulting in higher yields of radioisotopes with greater purity and consistency. Ring cyclotrons are well-suited for large-scale production in medical facilities owing to their efficiency, which guarantees a consistent supply of essential radiopharmaceuticals. Additionally, their advanced technology supports a wider range of isotopes, catering to diverse medical applications beyond oncology, such as cardiology and neurology. The combination of high production capacity, reliability, and versatility positions ring cyclotrons as the preferred choice in the medical cyclotron market.

Analysis by Product Type:

  • Cyclotron 10-12 MeV
  • Cyclotron 16-18 MeV
  • Cyclotron 19-24 MeV
  • Cyclotron 24 MeV and Above

Cyclotron 16-18 MeV led the market in 2024. The demand for cyclotrons with 16-18 MeV energy levels is mainly driven by their optimal balance between production capacity and operational efficiency. Fluorine-18, which is essential for PET imaging, is among the many radioisotopes that can be produced by these cyclotrons. The 16-18 MeV energy range allows for efficient production of high-purity isotopes with sufficient yield to meet the demands of both large hospitals and commercial radio pharmacies. Additionally, these cyclotrons are cost-effective, offering a favorable return on investment for medical facilities. Their versatility, combined with the ability to support diverse diagnostic and therapeutic applications, makes 16-18 MeV cyclotrons the preferred choice in the industry.

Analysis by End User:

  • Hospitals
  • Diagnostic Centers
  • Research and Academic Institutes
  • Others

Hospitals led the market in 2024. Medical cyclotron market insights exhibit hospitals as the biggest end users, with their critical role in providing advanced diagnostic and therapeutic services. Medical cyclotrons in hospitals produce essential radioisotopes used in PET and SPECT imaging, which are pivotal for diagnosing and monitoring various diseases, including cancer, CVDs, and neurological disorders. The integration of cyclotrons within hospital settings ensures a timely and reliable supply of these radiopharmaceuticals, enhancing patient care and treatment outcomes. Furthermore, the growing trend of in-house production of radioisotopes allows hospitals to reduce dependence on external suppliers, lower operational costs, and improve the efficiency of their nuclear medicine departments.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, Asia Pacific accounted for the largest market share. Medical cyclotron market analysis revealed Asia Pacific as the leading region due to robust healthcare infrastructure expansion, particularly in countries like China, Japan, and India, which boosts the demand for advanced diagnostic and therapeutic technologies. Increasing government investments and favorable policies support the adoption of medical cyclotrons in healthcare facilities. Additionally, the rising prevalence of cancer and other chronic diseases in the region amplifies the need for advanced imaging and treatment solutions, further driving market growth. The presence of leading cyclotron manufacturers and growing research and development (R&D) activities in nuclear medicine also contribute to the region's dominance.

Key Regional Takeaways:

United States Medical Cyclotron Market Analysis

The United States medical cyclotron market is primarily driven by the growing demand for advanced diagnostic imaging, particularly positron emission tomography (PET) scans used in oncology, cardiology, and neurology. The increasing incidence of cancer and chronic diseases has heightened the need for reliable radioisotope production, notably Fluorine-18, which is widely used in PET imaging. For instance, the National Cancer Institute estimates that there will be 2,041,910 new cases of cancer in 2025 and approximately 618,120 deaths due to cancer. With many traditional nuclear reactors being phased out or operating under strict regulations, medical cyclotrons provide a safer, decentralized alternative for isotope generation. Moreover, advancements in compact and automated cyclotron technologies have improved operational efficiency and reduced the infrastructure burden, enabling adoption even in mid-sized hospitals and diagnostic centers. The increasing demand for personalized medicine has further strengthened the role of on-site cyclotron production. Government investments, favorable reimbursement policies for PET procedures, and growing partnerships between public institutions and private firms are also propelling industry expansion. Additionally, FDA approvals for new radiopharmaceuticals and a focus on increasing domestic isotope production to reduce import reliance are expanding installations. The trend of integrating cyclotrons with radiochemistry labs for streamlined operations is also attracting attention from healthcare providers seeking to enhance service offerings and reduce lead times in isotope availability, particularly for time-sensitive radiotracers.

Asia Pacific Medical Cyclotron Market Analysis

The Asia Pacific medical cyclotron market is expanding due to increasing government support for indigenizing isotope production and strengthening national nuclear medicine programs. Several countries in the region are enhancing regulatory frameworks and offering funding incentives to encourage hospitals and academic centers to establish cyclotron facilities. Government initiatives to strengthen diagnostic capabilities, along with rising public and private healthcare expenditure, are facilitating cyclotron installations in both urban and tier-2 cities. For instance, from 2017-18 to 2023-24, expenditure on healthcare in India increased from 1.4% to 1.9%, as per the Press Information Bureau (PIB). Additionally, efforts to integrate cyclotron technology with automated radiopharmacy units are improving workflow efficiency and compliance with international safety standards. Local manufacturing of cyclotron components and turnkey radiopharmacy solutions is also gaining traction, lowering installation and maintenance costs. Academic research on novel radiotracers for diseases prevalent in Asia is further boosting demand for dedicated cyclotron facilities tailored to regional diagnostic priorities, facilitating industry expansion.

Europe Medical Cyclotron Market Analysis

The Europe medical cyclotron market is experiencing robust growth, fueled by the rising demand for radioisotopes in PET and SPECT imaging, driven by the increasing geriatric population and the growing prevalence of cancer, cardiovascular, and neurological diseases in the region. According to reports, cancer was the second leading cause of death in the European Union in 2021, with 1.1 Million deaths, which equated to 21.6% of the total number of deaths in the region. Additionally, male mortality rates from cancer were higher at 23.8% than female mortality rates at 19.4%. A strong emphasis on early and precise diagnosis is also prompting hospitals and diagnostic centers across Europe to invest in medical cyclotrons for in-house radiotracer production. Stringent regulatory frameworks around nuclear reactors and radioactive material are further leading to a shift toward decentralized, hospital-based cyclotron installations to ensure a stable and timely isotope supply. Moreover, the European Commission's initiatives to reduce dependency on imported medical isotopes and enhance domestic production capabilities are creating significant funding opportunities and research incentives. Technological advancements in compact and energy-efficient cyclotrons have made installations more feasible in smaller clinical settings, expanding the market beyond large academic centers. Other than this, collaborations between public health bodies, research institutions, and private sector players are fostering innovation and infrastructure development.

Latin America Medical Cyclotron Market Analysis

The Latin America medical cyclotron market is significantly influenced by the growing demand for advanced diagnostic imaging in oncology, neurology, and cardiology, along with increasing awareness about nuclear medicine applications. Countries such as Brazil, Mexico, and Argentina are expanding public and private healthcare investments to enhance diagnostic infrastructure, including PET-CT capabilities. According to the International Trade Administration (ITA), Brazil spends 9.47% of its GDP on healthcare, equating to USD 161 Billion and making the country the largest healthcare market in Latin America. Regional efforts to modernize healthcare systems and improve early disease detection are also supporting market growth. Besides this, strategic collaborations with international cyclotron manufacturers are helping reduce costs and improve access to training and operational support in the region, supporting industry expansion.

Middle East and Africa Medical Cyclotron Market Analysis

The Middle East and Africa medical cyclotron market is being increasingly propelled by rising investments in nuclear medicine infrastructure and growing demand for PET imaging in cancer diagnosis and management. Countries such as the UAE, Saudi Arabia, and South Africa are expanding advanced diagnostic services as part of broader healthcare modernization efforts. Moreover, medical tourism growth in Gulf countries and the establishment of specialized cancer treatment centers are further supporting cyclotron adoption. For instance, according to a report by the IMARC Group, the medical tourism market in Saudi Arabia reached USD 1,341.1 Million in 2024 and is expected to grow at a CAGR of 21.80% during 2025-2033. The limited availability of imported isotopes, combined with the need for timely and efficient radiotracer supply, is further driving interest in localized cyclotron facilities and propelling market growth.

Competitive Landscape:

The medical cyclotron market is experiencing growth driven by several key developments. Technological advancements have led to the creation of compact, energy-efficient cyclotrons, enhancing accessibility for healthcare facilities. Public-private partnerships and government funding are increasingly common, aiming to mitigate financial barriers and expand access to cyclotron technologies. Research and development efforts are focused on producing novel radioisotopes for diagnostic and therapeutic applications. Among these trends, government initiatives and funding stand out as prevalent practices, facilitating the establishment of cyclotron facilities and promoting nuclear medicine advancements.

The report provides a comprehensive analysis of the competitive landscape in the medical cyclotron market with detailed profiles of all major companies, including:

  • Advanced Cyclotron Systems Inc.
  • Alcen
  • Best Medical International Inc.
  • General Electric Company
  • IBA RadioPharma Solutions
  • Ionetix Corporation
  • Isosolution Inc.
  • Siemens AG
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems Inc.

Key Questions Answered in This Report

  • 1.How big is the medical cyclotron market?
  • 2.What is the future outlook of medical cyclotron market?
  • 3.What are the key factors driving the medical cyclotron market?
  • 4.Which region accounts for the largest medical cyclotron market share?
  • 5.Which are the leading companies in the global medical cyclotron market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Medical Cyclotron Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Ring Cyclotron
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Azimuthally Varying Field (AVF) Cyclotron
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Cyclotron 10-12 MeV
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cyclotron 16-18 MeV
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cyclotron 19-24 MeV
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cyclotron 24 MeV and Above
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research and Academic Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Advanced Cyclotron Systems Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Alcen
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Best Medical International Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 General Electric Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 IBA RadioPharma Solutions
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Ionetix Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Isosolution Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Siemens AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sumitomo Heavy Industries Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Varian Medical Systems Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Medical Cyclotron Market: Major Drivers and Challenges
  • Figure 2: Global: Medical Cyclotron Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Medical Cyclotron Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Medical Cyclotron Market: Breakup by Product Type (in %), 2024
  • Figure 6: Global: Medical Cyclotron Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Medical Cyclotron Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Medical Cyclotron (Ring Cyclotron) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Medical Cyclotron (Ring Cyclotron) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Medical Cyclotron (Azimuthally Varying Field Cyclotron) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Medical Cyclotron (Azimuthally Varying Field Cyclotron) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Medical Cyclotron (Cyclotron 10-12 MeV) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Medical Cyclotron (Cyclotron 10-12 MeV) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Medical Cyclotron (Cyclotron 16-18 MeV) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Medical Cyclotron (Cyclotron 16-18 MeV) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Medical Cyclotron (Cyclotron 19-24 MeV) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Medical Cyclotron (Cyclotron 19-24 MeV) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Medical Cyclotron (Cyclotron 24 MeV and Above) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Medical Cyclotron (Cyclotron 24 MeV and Above) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Medical Cyclotron (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Medical Cyclotron (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Medical Cyclotron (Diagnostic Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Medical Cyclotron (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Medical Cyclotron (Research and Academic Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Medical Cyclotron (Research and Academic Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Medical Cyclotron (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Medical Cyclotron (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Medical Cyclotron Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Medical Cyclotron Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Medical Cyclotron Industry: SWOT Analysis
  • Figure 78: Global: Medical Cyclotron Industry: Value Chain Analysis
  • Figure 79: Global: Medical Cyclotron Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Medical Cyclotron Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Medical Cyclotron Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Medical Cyclotron Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 4: Global: Medical Cyclotron Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Medical Cyclotron Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Medical Cyclotron Market: Competitive Structure
  • Table 7: Global: Medical Cyclotron Market: Key Players